Skip to search boxSkip to navigationSkip to main content

Furanocoumarins from ruta chalepensis with amebicide activity

  • Aldo Fabio Bazaldúa-Rodríguez
    ,
  • Ramiro Quintanilla-Licea
    ,
  • María Julia Verde-Star
    ,
  • Magda Elizabeth Hernández-García
    ,
  • Javier Vargas-Villarreal
    ,
  • Universidad Autonoma de Nuevo Leon
    ,
  • Centro de Investigaciones Biomédicas del Noreste (CIBIN)
    ,
Research Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication metrics

Metrics

SciVal
FWCI
0.90
SciVal
Author count
6
SciVal
Paper percentile
68
SciVal
Citations
16
Scopus
Citations

Abstract

Entamoeba histolytica (protozoan; family Endomoebidae) is the cause of amoebiasis, a disease related to high morbidity and mortality. Nowadays, this illness is considered a significant public health issue in developing countries. In addition, parasite resistance to conventional medicinal treatment has increased in recent years. Traditional medicine around the world represents a valuable source of alternative treatment for many parasite diseases. In a previous paper, we communicated about the antiprotozoal activity in vitro of the methanolic (MeOH) extract of Ruta chalepensis (Ru-taceae) against E. histolytica. The plant is extensively employed in Mexican traditional medicine. The following workup of the MeOH extract of R. chalepensis afforded the furocoumarins rutamarin (1) and chalepin (2), which showed high antiprotozoal activity on Entamoeba histolytica trophozoites employing in vitro tests (IC50 values of 6.52 and 28.95 µg/mL, respectively). Therefore, we offer a full scientific report about the bioguided isolation and the amebicide activity of chalepin and rutamarin.

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Article number

3684

Journal (Volume, Issue Number)

Molecules (Volume 26, Issue 12)

Publication milestones

  • Published - 02/06/2021

Publication status

Published - 02/06/2021

ISSN

1420-3049

Publication IDs

  • Scopus: 85110252853
  • PubMed: 34208750

Funding Details

Acknowledgments: We acknowledge CONACYT (Mexico) for the doctoral fellowship awarded to Aldo Fabio Bazaldúa Rodríguez and the support given throughout the development of this research project. We also thank Benito David Mata-Cardenas and Javier Vargas-Villarreal for providing the protozoa E. histolytica used in this research. We thank H. Laatsch of the University of Göttingen (Germany) for the spectroscopic measurements. We acknowledge CONACYT (Mexico) for the doctoral fellowship awarded to Aldo Fabio Bazaldúa Rodríguez and the support given throughout the development of this research project. We also thank Benito David Mata-Cardenas and Javier Vargas-Villarreal for providing the protozoa E. histolytica used in this research. We thank H. Laatsch of the University of Göttingen (Germany) for the spectroscopic measurements.
FundersFunding numbers
CONACYT
-
GAU
-